Private Equity

The apparel giant is using forensic analysis to prove its cotton's origin, a move that could redefine transparency and trust in the fashion industry.

Beztak's entire All Seasons portfolio receives top honors from U.S. News, setting a new benchmark for quality in a booming and competitive market.

Celebrating 7 years, Edye thrives by offering a safe, curated alternative to mainstream kids' content for Hispanic families in a crowded streaming market.

Private equity firm STG acquires Carrier Logistics Inc. to build an AI-native operating system, aiming to revolutionize the LTL freight industry.

A landmark partnership with Blue Star Innovation Partners will fuel IntusCare's AI platform, aiming to revolutionize the complex, high-growth PACE market.

With 62 profitable quarters and a major new acquisition, BioSyent prepares to pitch its proven growth strategy to top healthcare investors in Toronto.

Fengate launches Fengate Communities, a new brand to deliver 25,000 homes and tackle Canada's housing shortage when other developers are pulling back.

The shipping firm posts a stunning $17.6M Q4 profit, reversing a major loss, thanks to a new asset management arm and a leaner, greener fleet.

Aetrex and Tradehome Shoes will provide free 3D foot scans and custom orthotics to thousands of athletes at the 2026 Special Olympics USA Games.

The strategic acquisition of Axip Energy's assets positions Service Compression as a powerhouse in the booming natural gas compression market.

A new US-DRC partnership aims to create an ethical cobalt supply chain, challenging Chinese dominance and revitalizing American mineral processing.

A company named for mining is betting big on Bali's luxury villa market. But with a tiny market cap and an unknown builder, is it a brilliant pivot or a risky gamble?

The struggling footwear brand is selling its assets to become NewBird AI, a GPU provider. Is it a visionary gamble or a desperate move in the AI gold rush?

A CEO's personal battle with prostate cancer inspired a community golf tournament that is now on the verge of raising $1 million for critical research.

Backed by Bain Capital and a veteran team, the new biotech has a de-risked pipeline from Bristol Myers Squibb aimed at transforming care for lupus and more.

Investors eye BioCryst's May 6th report for insights into ORLADEYO's growth, a pivotal acquisition, and its strategy in the competitive rare disease market.

After devastating storms, The Ritz-Carlton Oʻahu, Turtle Bay, calls for respectful tourism to help rebuild the North Shore's economy and community.

Slate Aviation adds Westhampton and Nantucket routes, tapping into a booming market for per-seat private flights that blend luxury with convenience.

A parent-led company gains a U.S. patent for a diazoxide formulation, offering new hope for managing behavioral symptoms in Prader-Willi syndrome.

Despite a historic tariff shock, new data shows middle market dealmaking adapted and thrived, with private equity rewriting its playbook for a new era.